Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LABP | AZN | AMGN | GILD | GSK |
| Company | Landos Biopharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 22.93 | 206.60 | 372.01 | 150.58 | 59.87 |
| High | 22.94 | 207.69 | 377.00 | 153.26 | 60.05 |
| Low | 22.75 | 205.66 | 371.39 | 150.09 | 59.57 |
| Latest | 22.93 | 206.15 | 374.61 | 151.77 | 59.48 |
| Change | +0.13 | -0.30 | -0.89 | +0.65 | -0.89 |
| % Change | +0.58% | -0.15% | -0.24% | +0.43% | -1.47% |
| Volume | 50,800 | 335,452 | 336,994 | 1,008,014 | 621,827 |
| 20-Day Average Volume | 11,285 | 2,837,625 | 2,887,187 | 8,108,145 | 6,382,088 |
| Previous Close | 22.80 | 206.45 | 375.50 | 151.12 | 60.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.35 | 194.63 | 360.97 | 147.19 | 56.07 |
| 20-Day Raw Stochastic | 99.03% | 79.15% | 76.21% | 83.89% | 84.95% |
| 20-Day Relative Strength | 81.09 | 64.14 | 61.66 | 65.07 | 69.07 |
| Weighted Alpha | +234.26 | +48.46 | +31.98 | +50.26 | +74.80 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 64% Buy | 88% Buy | 96% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.83% since 05/16/24 | +0.96% since 02/12/26 | +2.11% since 02/12/26 | +0.82% since 02/12/26 | +2.02% since 02/12/26 |
| Low | 22.20 on 05/20/24 | 204.09 on 02/13/26 | 361.71 on 02/13/26 | 150.09 on 02/20/26 | 58.56 on 02/13/26 |
| High | 22.94 on 05/23/24 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | +3.52% since 04/23/24 | +14.79% since 01/20/26 | +12.97% since 01/20/26 | +23.29% since 01/20/26 | +25.33% since 01/20/26 |
| Low | 21.91 on 05/02/24 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 47.77 on 01/21/26 |
| High | 22.94 on 05/23/24 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | +264.55% since 02/23/24 | +16.42% since 11/20/25 | +11.26% since 11/20/25 | +22.45% since 11/20/25 | +29.52% since 11/20/25 |
| Low | 5.57 on 03/11/24 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 46.47 on 11/21/25 |
| High | 22.94 on 05/23/24 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +418.78% since 11/22/23 | +28.22% since 08/20/25 | +26.13% since 08/20/25 | +28.91% since 08/20/25 | +49.04% since 08/20/25 |
| Low | 3.21 on 12/22/23 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 22.94 on 05/23/24 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 71,674 | 323,550,432 | 202,420,032 | 187,491,552 | 124,037,000 |
| Shares Outstanding, K | 3,126 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -21,940,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -8,900,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 0.14 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.43 on 05/09/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 08/14/24 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.76 | 17.38 | 18.74 | 13.54 |